AzTrials
AzTrials

CaregiversNCT03069105

An Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With Cancer

An observational study of Caregivers and Cancer, run by Saint John's Cancer Institute at 4 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will look at caregiver burden and the coping behavior of caregivers of patients with cancer. Through this study, the investigators will identify the relationship between cognitive dysfunction (measured as a proxy rating by the caregiver), resilience, social support, cognitive appraisal, coping behavior, and… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Caregivers, Cancer
What is being tested?
Questionnaire
How many people
49 participants
Where
4 sitesUnited States
Study dates
23 Feb 2017to 28 Apr 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The sample for this study will consist of caregivers of persons with cancer. A convenience sampling will be used to enroll eligible caregivers.

Who may be able to join

  • Age ≥ 18 years
  • Self-identified primary caregiver of patients with cancer
  • Co-residence with the patient
  • Providing a minimum of 4 hours of direct care for at least 3 days per week
  • Able to speak, read, and understand English
  • Willing to participate in completion of surveys

Who cannot join

  • Professional or paid caregivers

Trial locations and contacts

4 sites in 1 country.

United States4 sites
  • Providence Saint Joseph Medical Center

    Burbank, California, 91505

  • Providence Holy Cross Medical Center

    Mission Hills, California, 91345

  • EndBrainCancer Initiative/Chris Elliott Fund

    Redmond, Washington, 98052

  • John Wayne Cancer Institute at Providence Saint John's Health Center

    Santa Monica, California, 90404

Other trials in United States

About this study

Official title: An Exploratory Study of Caregiver Burden Among Family Caregivers of Cancer Patients

This study will look at caregiver burden and the coping behavior of caregivers of patients with cancer. Through this study, the investigators will identify the relationship between cognitive dysfunction (measured as a proxy rating by the caregiver), resilience, social support, cognitive appraisal, coping behavior, and caregiver burden, anxiety, and depression among family caregivers of patients with cancer.

Read the detailed description

The goal of this study is to explore caregiver burden and the coping behavior of caregivers of patients with cancer. It has been documented that non-professional caregivers and long-term care providers to patients with cancer receive little preparation, information, or support to perform their vital role. Through this study, the investigators will identify the relationship between cognitive dysfunction, resilience, social support, cognitive appraisal, coping behavior, and caregiver burden, anxiety, and depression among family caregivers of patients with cancer. The findings of this study will direct future intervention studies to reduce caregiver burden and improve outcomes for the many individuals caring for family members with cancer.

Conditions
Caregivers, Cancer
Being tested
Questionnaire
Medical subject headings
Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    Participants will complete paper and pencil or electronic questionnaires at the cancer center or in the privacy of their own homes.

Study groups in NCT03069105
Study groupRoleWhat they receive
Family caregiversThe sample for this study will consist of caregivers of patients with cancer. Eligible subjects who agrees to participate in the research study and sign the consent form will participate by completing paper and pencil or electronic questionnaires.
Receives: Other: Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Caregiver Burden Score [Caregiver Reaction Assessment (CRA)]

    Relation between caregiver burden subscale scores and caregiver resilience, social support, and coping

    Measured: 1 year

Secondary outcomes (1)
  1. Changes in Anxiety and Depression Score [Hospital Anxiety and Depression Scale (HADS)]

    Relation between caregiver anxiety and depression score and caregiver resilience, social support, and coping

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2017
  2. Study start23 Feb 2017
  3. Primary completion28 Apr 2020
  4. Study completion28 Apr 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03069105
Sponsor's protocol ID
JWCI-16-1201
Status last verified
Nov 2020
First submitted
23 Feb 2017
Last updated
13 Nov 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Saria MG, Nyamathi A, Phillips LR, Stanton AL, Evangelista L, Kesari S, Maliski S. The Hidden Morbidity of Cancer: Burden in Caregivers of Patients with Brain Metastases. Nurs Clin North Am. 2017 Mar;52(1):159-178. doi: 10.1016/j.cnur.2016.10.002.

    PubMed 28189161
  • Saria MG, Courchesne N, Evangelista L, Carter J, MacManus DA, Gorman MK, Nyamathi AM, Phillips LR, Piccioni D, Kesari S, Maliski S. Cognitive dysfunction in patients with brain metastases: influences on caregiver resilience and coping. Support Care Cancer. 2017 Apr;25(4):1247-1256. doi: 10.1007/s00520-016-3517-3. Epub 2016 Dec 5.

    PubMed 27921222

Questions about this trial

What is this clinical trial studying?

An observational study of Caregivers and Cancer, run by Saint John's Cancer Institute at 4 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Caregiver Burden Score [Caregiver Reaction Assessment (CRA)] (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03069105, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in